Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2026-03-26 @ 3:16 PM
Ignite Modification Date:
2026-03-26 @ 3:16 PM
NCT ID:
NCT07315204
Eligibility Criteria:
Inclusion Criteria:
* Age \>18 years
* Any graft type (DBD or DCD)
* Any underlying recipient disease (i.e., end stage, liver tumour)
* Any other donor risk factors and static cold storage time prior to NMP accepted by the participating center for transplantation in context of OrganOx metra use
* Patients undergoing primary deceased donor liver transplantation where back-to-base NMP is used (OrganOx metra) from July 15, 2025 to December 31, 2027. (CCF only)
* Patients who have undergone deceased donor liver transplantation where back-to-base NMP was used (OrganOx metra) from October 22, 2022 to July 14, 2025. (CCF only)
Exclusion Criteria:
* Patients receiving a liver graft that is not perfused with OrganOx metra
* Pediatric recipients (\<18years)
* Patients listed for super urgent liver transplantation due to acute liver failure
* Patients receiving combined organ transplant (heart+liver, lung+liver, liver+kidney, liver+intestine)
* Patients receiving living donor liver transplant or a split (or reduced) liver transplantation or a domino graft.
* Re-transplantations
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT07315204
Study Brief:
Protocol Section:
NCT07315204